Authors: JAGER W ZEMBSCH B WOLSCHANN P PITTENAUER E SENDEROWICZ AM SAUSVILLE EA SEDLACEK HH GRAF J THALHAMMER T

Citation: W. Jager et al., METABOLISM OF THE ANTICANCER DRUG FLAVOPIRIDOL, A NEW INHIBITOR OF CYCLIN-DEPENDENT KINASES, IN RAT-LIVER, Life sciences, 62(20), 1998, pp. 1861-1873

Authors: BRUSSELBACH S NETTELBECK DM SEDLACEK HH MULLER R

Citation: S. Brusselbach et al., CELL CYCLE-INDEPENDENT INDUCTION OF APOPTOSIS BY THE ANTITUMOR DRUG FLAVOPIRIDOL IN ENDOTHELIAL-CELLS, International journal of cancer, 77(1), 1998, pp. 146-152

Authors: SEDLACEK HH CZECH J NAIK R KAUR G WORLAND P LOSIEWICZ M PARKER B CARLSON B SMITH A SENDEROWICZ A SAUSVILLE E

Citation: Hh. Sedlacek et al., FLAVOPIRIDOL (L86-8275,NSC-649890), A NEW KINASE INHIBITOR FOR TUMOR-THERAPY, International journal of oncology, 9(6), 1996, pp. 1143-1168

Authors: CZECH J HOFFMANN D NAIK R SEDLACEK HH

Citation: J. Czech et al., ANTITUMORAL ACTIVITY OF FLAVONE L-86-8275, International journal of oncology, 6(1), 1995, pp. 31-36

Authors: SEDLACEK HH

Citation: Hh. Sedlacek, VACCINATION FOR TREATMENT OF TUMORS - A CRITICAL COMMENT, Critical reviews in oncogenesis, 5(6), 1994, pp. 555-587

Authors: GEHRMANN MC OPPER M SEDLACEK HH BOSSLET K CZECH J

Citation: Mc. Gehrmann et al., BIOCHEMICAL-PROPERTIES OF RECOMBINANT HUMAN BETA-GLUCURONIDASE SYNTHESIZED IN BABY HAMSTER-KIDNEY CELLS, Biochemical journal, 301, 1994, pp. 821-828